Consequences of the COVID-19 pandemic for patients with metabolic diseases

Affiliations

• ¹ Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany. stefan.bornstein@ukdd.de.
• ² Department of Diabetes, School of Life Course Science and Medicine, King's College London, London, UK. stefan.bornstein@ukdd.de.
• ³ Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland. stefan.bornstein@ukdd.de.
• ⁴ Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Faculty of Medicine of the TU Dresden, Dresden, Germany. stefan.bornstein@ukdd.de.
• ⁵ German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany. stefan.bornstein@ukdd.de.
• ⁶ Department of Diabetes, School of Life Course Science and Medicine, King's College London, London, UK.
• ⁷ Bariatric and Metabolic Surgery, King's College Hospital, London, UK.
• ⁸ Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany.
• ⁹ Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland.
• ¹⁰ Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Faculty of Medicine of the TU Dresden, Dresden, Germany.
• ¹¹ German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.
• ¹² DFG-Center for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany.
• ¹³ Diabetes Research Centre, University of Leicester, Leicester, UK.
• ¹⁴ Institute of Diabetes Endocrinology and Obesity, King's Health Partners, London, UK.
• ¹⁵ Department of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Tübingen, Germany.
• ¹⁶ Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany.
• ¹⁷ Deutsches Zentrum für Diabetesforschung, DZD e.V., Neuherberg, Germany.
• ¹⁸ Department of Endocrinology, Tan Tock Seng Hospital, Singapore, Singapore.
• ¹⁹ Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
• ²⁰ Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
• ²¹ Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
• ²² Amsterdam UMC, Internal Medicine, University of Amsterdam, Amsterdam, the Netherlands.
• ²³ Profil Institute for Metabolic Research, Neuss, Germany.
• ²⁴ Montpellier University Hospital and Institute of Functional Genomics, CNRS, INSERM, University of Montpellier, Montpellier, France.
• ²⁵ Division of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
• ²⁶ Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
• ²⁷ Imperial College, London, UK.
• ²⁸ Obesity and Comorbidities Research Center (OCRC), Laboratory of Investigation in Metabolism and Diabetes (LIMED)/Gastrocentro, Universidade de Campinas (UNICAMP), Campinas, Brazil.
• ²⁹ Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity and Li Ka Shing Institute of Health Science, Chinese University of Hong Kong and Prince of Wales Hospital, Hong Kong SAR, China.
• ³⁰ Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé, Yaounde, Cameroon.
• ³¹ Endocrine, Diabetes and Metabolic Unit, Department of Internal Medicine, Nile University of Nigeria/Asokoro Hospital, Abuja, Nigeria.
• ³² India Diabetes Research Foundation, Dr A Ramachandran's Diabetes Hospitals, Chennai, India.
• ³³ Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Karachi, Pakistan.
• ³⁴ Dubai Hospital, Dubai Health Authority and Gulf Medical University, Dubai, United Arab Emirates.
• ³⁵ Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
• ³⁶ Università Cattolica del Sacro Cuore, Rome, Italy.